COPENHAGEN, Denmark, July 23, 2024 /PRNewswire/ — Delivering our highest ever quarterly sales amounting to USD 217 million Organic growth of 6% for Q2 driven strong performance in Prosthetics & Neuro Orthotics and Patient Care EBITDA was USD 47 million and EBITDA margin was 22% for Q2…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.